31 – 40 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
The androgen receptor and stem cell pathways in prostate and bladder cancers (Review)
(
- Contribution to journal › Scientific review
-
Mark
Overcoming Drug Resistance and Treating Advanced Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
DNA Methylation in ATRA-treated Leukemia Cell Lines Lacking a PML-RAR Chromosome Translocation.
(
- Contribution to journal › Article
- 2011
-
Mark
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer
(
- Contribution to journal › Article
- 2010
-
Mark
Exploring novel therapeutic options in T-LGL, including epigenetic modulation: A case report.
(
- Contribution to journal › Letter
- 2009
-
Mark
CYCLIN A1 MEDIATES DRUG-RESISTANT METASTATIC SPREAD OF PCA CELLS IN XENOGRAFTS IN VIVO
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.343-343(
- Contribution to journal › Published meeting abstract
-
Mark
Expression Of Pten And Shp1, Investigated From Tissue Microarrays In Pediatric Acute Lymphoblastic, Leukemia
(
- Contribution to journal › Article
-
Mark
Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G(2)/m checkpoint accompanied by alterations in Erk and Akt kinase activities.
(
- Contribution to journal › Article
-
Mark
Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.
(
- Contribution to journal › Article
- 2008
-
Mark
Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival
(
- Contribution to journal › Article